Current through Register Vol. 30, No. 38, September 20, 2024
A.
Electronic brachytherapy devices used to deliver interstitial and intracavitary
therapeutic radiation dosage shall be subject to the requirements of this
Section, and unless otherwise specified in this Section shall be exempt from
the requirements of
R9-7-611.
1. An electronic brachytherapy device that
does not meet the requirements of this Section shall not be used for
irradiation of patients; and
2. An
electronic brachytherapy device shall only be utilized for human use
applications specifically approved by the U.S. Food and Drug Administration
(FDA), unless participating in a research study approved by the registrant's
Institutional Review Board (IRB).
B. Each facility location authorized to use
an electronic brachytherapy device in accordance with this Section shall
possess appropriately calibrated portable monitoring equipment. At a minimum,
such equipment shall include a portable survey instrument capable of measuring
dose rates over the range 10 µSv (1 mrem) per hour to 10 mSv (1000 mrem) per
hour. The survey instrument shall be capable of measuring as low as 10 µSv (1
mrem) per hour in the energy range of the electronic brachytherapy unit for
which the survey instrument is to be used. Published correction factors
utilized in conjunction with the instrument's readings may be used to achieve
sensitivity. The survey instrument or instruments shall be operable and
calibrated before first use, at intervals not to exceed 12 months, and after
survey instrument repairs.
C.
Facility Design Requirements for Electronic Brachytherapy Devices. In addition
to shielding adequate to meet requirements of
R9-7-603(C),
the treatment room shall meet the following design requirements:
1. If applicable, provision shall be made to
prevent simultaneous operation of more than one therapeutic radiation machine
in a treatment room.
2. Access to
the treatment room shall be controlled by a door at each entrance.
3. Each treatment room shall have provisions
to permit continuous oral communication and visual observation of the patient
from the treatment control panel during irradiation. The electronic
brachytherapy device shall not be used for patient irradiation unless the
patient can be observed.
4. For
electronic brachytherapy devices capable of operating below 150 kVp, radiation
shielding for the staff in the treatment room may be available, either as a
portable shield or as localized shielded material around the treatment site or
both, in lieu of the requirements for room shielding. The shielding shall meet
the requirements of
R9-7-603(C).
5. For electronic brachytherapy devices
capable of operating at or greater than 150 kVp, the facility must meet the
requirements of
R9-7-611(B)(4).
D. Control Panel Functions. The
control panel, in addition to the displays required by other provisions in this
Section, shall:
1. Provide an indication of
whether electrical power is available at the control panel and if activation of
the electronic brachytherapy source is possible;
2. Provide an indication of whether x-rays
are being produced;
3. Provide a
means for indicating electronic brachytherapy source potential and
current;
4. Provide the means for
terminating an exposure at any time; and
5. Include an access control (locking) device
that will prevent unauthorized use of the electronic brachytherapy
device.
E. Timer. A
suitable irradiation control device (timer) shall be provided to terminate the
irradiation after a pre-set time interval or integrated charge on a
dosimeter-based monitor.
1. A timer shall be
provided at the treatment control panel. The timer shall indicate the planned
setting and the time elapsed or remaining;
2. The timer shall not permit an exposure if
set at zero;
3. The timer shall be
a cumulative device that activates with an indication of "BEAM-ON" that retains
its reading after irradiation is interrupted or terminated. After irradiation
is terminated and before irradiation can be reinitiated, it shall be necessary
to reset the elapsed time indicator;
4. The timer shall terminate irradiation when
a pre-selected time has elapsed, if any dose monitoring system has not
previously terminated irradiation.
5. The timer shall permit setting of exposure
times as short as 0.1 second; and
6. The timer shall be accurate to within one
percent of the selected value or 0.1 second, whichever is greater.
F. Qualified Medical Physicist
Support.
1. The services of a Qualified
Medical Physicist shall be required in facilities having electronic
brachytherapy devices. The Qualified Medical Physicist shall be responsible
for:
a. Evaluation of the output from the
electronic brachytherapy source;
b.
Generation of the necessary dosimetric information;
c. Supervision and review of treatment
calculations prior to initial treatment of any treatment site;
d. Establishing the periodic and day-of-use
quality assurance checks and reviewing the data from those checks as required
in subsection (J);
e. Consultation
with the authorized user in treatment planning, as needed; and
f. Performing calculations/assessments
regarding patient treatments that may constitute a medical event.
2. If the Qualified Medical
Physicist is not a full-time employee of the registrant, then the operating
procedures required by subsection (G) shall also specifically address how the
Qualified Medical Physicist is to be contacted for problems or emergencies, as
well as the specific actions, if any, to be taken until the Qualified Medical
Physicist can be contacted.
G. Operating Procedures.
1. Only individuals approved by the
authorized user, Radiation Safety Officer, or Qualified Medical Physicist shall
be present in the treatment room during treatment;
2. Electronic brachytherapy devices shall not
be made available for medical use unless the requirements of subsections (A),
(H), and (I) have been met;
3. The
electronic brachytherapy device shall be inoperable, either by hardware or
password, when unattended by qualified staff or service personnel;
4. During operation, the electronic
brachytherapy device operator shall monitor the position of all persons in the
treatment room, and all persons entering the treatment room, to prevent
entering persons from unshielded exposure from the treatment beam;
5. If a patient must be held in position
during treatment, mechanical supporting or restraining devices shall be
used;
6. Written procedures shall
be developed, implemented, and maintained for responding to an abnormal
situation. These procedures shall include:
a.
Instructions for responding to equipment failures and the names of the
individuals responsible for implementing corrective actions; and
b. The names and telephone numbers of the
authorized users, the Qualified Medical Physicist, and the Radiation Safety
Officer to be contacted if the device or console operates abnormally.
7. A copy of the current operating
and emergency procedures shall be physically located at the electronic
brachytherapy device control console;
8. Instructions shall be maintained with the
electronic brachytherapy device control console to inform the operator of the
names and telephone numbers of the authorized users, the Qualified Medical
Physicist, and the Radiation Safety Officer to be contacted if the device or
console operates abnormally; and
9.
The Radiation Safety Officer, or the Radiation Safety Officer's designee, and
an authorized user shall be notified immediately if the patient has a medical
emergency, suffers injury or dies. The Radiation Safety Officer or the
Qualified Medical Physicist shall inform the manufacturer of the
event.
H. Safety
Precautions for Electronic Brachytherapy Devices.
1. Any person in the treatment room, other
than the person being treated, shall wear personnel monitoring
devices;
2. An authorized user and
a Qualified Medical Physicist shall be physically present during the initiation
of all new patient treatments involving the electronic brachytherapy
device;
3. After the first
treatment one of the following individuals shall be physically present during
continuation of all patient treatments involving the electronic brachytherapy
device:
a. A Qualified Medical Physicist,
or
b. An authorized user,
or
c. A certified therapy
technologist (CTT) certified by the Arizona Medical Radiologic Technology Board
of Examiners, under the direct supervision of an authorized user, who has been
trained in the operation and emergency response for the electronic
brachytherapy device;
4.
When shielding is required by subsection (C)(4), surveys shall be conducted to
ensure that the requirements of
R9-7-408,
R9-7-414,
and
R9-7-416
are met. Alternatively, a Qualified Medical Physicist shall designate shield
locations sufficient to meet the requirements of
R9-7-603(C)
and
R9-7-607(C)
for any individual, other than the patient, in the treatment room;
and
5. All personnel in the
treatment room are required to remain behind shielding during treatment. A
Qualified Medical Physicist shall approve any deviation from this requirement
and shall designate alternative radiation safety protocols, compatible with
patient safety, to provide an equivalent degree of
protection.
I. Electronic
Brachytherapy Source Calibration Measurements.
1. Calibration of the electronic
brachytherapy source output shall be performed by, or under the direct
supervision of, a Qualified Medical Physicist. If the control console is
integral to the electronic brachytherapy device, the required procedures shall
be kept where the operator is located during electronic brachytherapy device
operation;
2. Calibration of the
electronic brachytherapy source output shall be made for each electronic
brachytherapy source, or after any repair affecting the x-ray beam generation,
or when indicated by the electronic brachytherapy source quality assurance
checks;
3. Calibration of the
electronic brachytherapy source output shall utilize a dosimetry system
appropriate for the energy output of the unit and calibrated by the National
Institute for Standards and Technology (NIST) or by an American Association of
Physicists in Medicine (AAPM) Accredited Dosimetry Calibration Laboratory
(ADCL). The calibration shall have been performed within the previous 24 months
and after any servicing that may have affected system calibration;
4. Calibration of the electronic
brachytherapy source output shall include, as applicable, determination of:
a. The output within two percent of the
expected value, if applicable, or determination of the output if there is no
expected value;
b. Timer accuracy
and linearity over the typical range of use;
c. Proper operation of back-up exposure
control devices;
d. Evaluation that
the relative dose distribution about the source is within five percent of that
expected; and
e. Source positioning
accuracy to within one millimeter within the applicator;
5. Calibration of the x-ray source output
required shall be in accordance with current published recommendations from a
recognized national professional association with expertise in electronic
brachytherapy (when available). In the absence of a calibration protocol
published by a national professional association, the manufacturer's
calibration protocol shall be followed.
6. The registrant shall maintain a record of
each calibration in an auditable form for the duration of the registration. The
record shall include: the date of the calibration; the manufacturer's name,
model number and serial number for the electronic brachytherapy device and a
unique identifier for its electronic instrument or instruments brachytherapy
source; the model numbers and serial numbers of the instrument or instruments
used to calibrate the electronic brachytherapy device; and the name and
signature of the Qualified Medical Physicist responsible for performing the
calibration.
J. Periodic
and Day-of-Use Quality Assurance Checks for Electronic Brachytherapy Devices.
1. Quality assurance checks shall be
performed on each electronic brachytherapy device:
a. At the beginning of each day of
use;
b. Each time the device is
moved to a new room or site; and
c.
After each x-ray tube installation.
2. The registrant shall perform periodic
quality assurance checks required in accordance with procedures established by
the Qualified Medical Physicist;
3.
To satisfy the requirements of this subsection, radiation output quality
assurance checks shall include at a minimum:
a. Verification that output of the electronic
brachytherapy source falls within three percent of expected values, as
appropriate for the device, as determined by:
i. Output as a function of time, or
ii. Output as a function of setting on a
monitor chamber.
b.
Verification of the consistency of the dose distribution to within three
percent (or the manufacturer's or Qualified Medical Physicist's documented
recommendation not to exceed five percent), observed at the source calibration
required by subsection (I); and
c.
Validation of the operation of positioning methods to ensure that the treatment
dose exposes the intended location within one millimeter; and
4. The registrant shall use a
dosimetry system that has been intercompared within the previous 12 months with
the dosimetry system described in this Section to make the quality assurance
checks required in subsection (J)(3);
5. The registrant shall review the results of
each radiation output quality assurance check to ensure that:
a. An authorized user and Qualified Medical
Physicist are immediately notified if any parameter is not within its
acceptable tolerance, and the electronic brachytherapy device is not used until
the Qualified Medical Physicist has determined that all parameters are within
their acceptable tolerances;
b. If
all radiation output quality assurance check parameters appear to be within
their acceptable range, the acceptable quality assurance checklist shall be
reviewed and signed by either the authorized user or Qualified Medical
Physicist prior to the next patient use of the unit. In addition, the Qualified
Medical Physicist shall review and sign the results of each radiation output
quality assurance check at intervals not to exceed 30 days.
6. To satisfy the requirements of
subsection (J)(1), safety device quality assurance checks shall, at a minimum,
assure:
a. Proper operation of radiation
exposure indicator lights on the electronic brachytherapy device and on the
control console;
b. Proper
operation of viewing and intercom systems in each electronic brachytherapy
facility, if applicable;
c. Proper
operation of radiation monitors, if applicable;
d. The integrity of all cables, catheters or
parts of the device that carry high voltages; and
e. Connecting guide tubes, transfer tubes,
transfer-tube-applicator interfaces, and treatment spacers are free from any
defects that interfere with proper operation.
7. If the results of the safety device
quality assurance checks required in subsection (J)(6) indicate the malfunction
of any system, a registrant shall secure the control console in the OFF
position and not use the electronic brachytherapy device except as may be
necessary to repair, replace, or check the malfunctioning system.
8. The registrant shall maintain a record of
each quality assurance check required by this Section in a legible form for
three years.
a. The record shall include the
date of the quality assurance check; the manufacturer's name, model number and
serial number for the electronic brachytherapy device; the name and signature
of the individual who performed the periodic quality assurance check and the
name and signature of the Qualified Medical Physicist who reviewed the quality
assurance check;
b. For radiation
output quality assurance checks required by subsection (J)(3), the record shall
also include the unique identifier for the electronic brachytherapy source and
the manufacturer's name; model number and serial number for the instrument or
instruments used to measure the radiation output of the electronic
brachytherapy device.
K. Therapy-related Computer Systems. The
registrant shall perform acceptance testing on the treatment planning system of
electronic brachytherapy-related computer systems in accordance with current
published recommendations from a recognized national professional association
with expertise in electronic brachytherapy (when available). In the absence of
an acceptance testing protocol published by a national professional
association, the manufacturer's acceptance testing protocol shall be followed.
1. Acceptance testing shall be performed by,
or under the direct supervision of a Qualified Medical Physicist. At a minimum,
the acceptance testing shall include, as applicable, verification of:
a. The source-specific input parameters
required by the dose calculation algorithm;
b. The accuracy of dose, dwell time, and
treatment time calculations at representative points;
c. The accuracy of isodose plots and graphic
displays;
d. The accuracy of the
software used to determine radiation source positions from radiographic images;
and
e. If the treatment planning
system is different from the treatment delivery system, the accuracy of
electronic transfer of the treatment delivery parameters to the treatment
delivery unit from the treatment planning system.
2. The position indicators in the applicator
shall be compared to the actual position of the source or planned dwell
positions, as appropriate, at the time of commissioning.
3. Prior to each patient treatment regimen,
the parameters for the treatment shall be evaluated for correctness and
approved by the authorized user and the Qualified Medical Physicist through
means independent of that used for the determination of the
parameters.
L. Training
for e-brachytherapy Authorized Users.
1. The
registrant for any therapeutic radiation machine subject to this Section shall
require the authorized user to be a physician who is:
a. Certified in:
i. Radiation oncology or therapeutic
radiology by the American Board of Radiology or radiology (combined diagnostic
and therapeutic radiology program) by the American Board of Radiology prior to
1976; or
ii. Radiation oncology by
the American Osteopathic Board of Radiology; or
iii. Radiology, with specialization in
radiotherapy, as a British "Fellow of the Faculty of Radiology" or "Fellow of
the Royal College of Radiology"; or
iv. Therapeutic radiology by the Canadian
Royal College of Physicians and Surgeons; or
b. In the active practice of therapeutic
radiology, and has completed 200 hours of instruction in basic radiation
techniques applicable to the use of an external beam radiation therapy unit,
500 hours of supervised work experience, and a minimum of three years of
supervised clinical experience.
2. To satisfy the requirement in subsection
(L)(1)(b) for:
a. Instruction, the classroom
and laboratory training shall include:
i.
Radiation physics and instrumentation;
ii. Radiation protection;
iii. Mathematics pertaining to the use and
measurement of ionization radiation; and
iv. Radiation biology;
b. Supervised work experience, training shall
be under the supervision of an authorized user and shall include:
i. Review of the full calibration
measurements and periodic quality assurance checks;
ii. Evaluation of prepared treatment plans
and calculation of treatment times or patient treatment settings or
both;
iii. Using administrative
controls to prevent medical events as described in
R9-7-444;
iv. Implementing emergency procedures to be
followed in the event of the abnormal operation of an external beam radiation
therapy unit or console; and
v.
Checking and using radiation survey meters; and
c. A period of supervised clinical
experience, training shall include one year in a formal training program
approved by the Residency Review Committee for Radiology of the Accreditation
Council for Graduate Medical Education or the Council on Postdoctoral Training
of the American Osteopathic Association and an additional two years of clinical
experience in therapeutic radiology under the supervision of an authorized
user. The supervised clinical experience shall include:
i. Examining individuals and reviewing their
case histories to determine their suitability for external beam radiation
therapy treatment, and any limitations or contraindications or both;
ii. Selecting proper dose and how it is to be
administered;
iii. Calculating the
therapeutic radiation machine doses and collaborating with the authorized user
in the review of patients' progress and consideration of the need to modify
originally prescribed doses or treatment plans as warranted by patients'
reaction to radiation or both; and
iv. Post-administration follow-up and review
of case histories.
3. A physician shall not act as an authorized
user until such time as the physician's training has been reviewed and approved
by the Department.
4.
Notwithstanding the requirements of subsections (L)(1) through (L)(3), the
registrant for any therapeutic radiation machine subject to this Section may
also submit the training of the prospective authorized user physician for
Department review on a case-by-case basis if the training includes
substantially equivalent training as that listed in subsections (L)(1)(b) and
(L)(2) and the training includes dosimetry calculation training and
experience.
M. Training
for Qualified Medical Physicist. The registrant for any therapeutic radiation
machine subject to this Section shall require the Qualified Medical Physicist
to:
1. Be certified with the Department, as a
provider of radiation services in the area of calibration and compliance
surveys of external beam radiation therapy units; and
2. Be certified by the American Board of
Radiology in:
a. Therapeutic radiological
physics; or
b. Roentgen-ray and
gamma-ray physics; or
c. X-ray and
radium physics; or
d. Radiological
physics; or
3. Be
certified by the American Board of Medical Physics in Radiation Oncology
Physics; or
4. Be certified by the
Canadian College of Physicists in Medicine; or
5. Hold a master's or doctor's degree in
physics, medical physics, other physical science, engineering, or applied
mathematics from an accredited college or university, and have completed one
year of full-time training in medical physics and an additional year of
full-time work experience under the supervision of a Qualified Medical
Physicist at a medical institution. This training and work experience shall be
conducted in clinical radiation facilities that provide high-energy external
beam radiation therapy (photons and electrons with energies greater than or
equal to one MV/one MeV). To meet this requirement, the individual shall have
performed the tasks listed in this subsection under the supervision of a
Qualified Medical Physicist during the year of work experience.
N. Qualifications of Operators.
Individuals who will be operating a therapeutic radiation machine for medical
use shall be certified by the Department as a CTT by the Arizona Medical
Radiologic Technology Board of Examiners.
O. Additional training requirements.
1. A registrant shall provide instruction,
initially and at least annually, to all individuals who operate the electronic
brachytherapy device, as appropriate to the individual's assigned duties, in
the operating procedures identified in subsection (G). If the interval between
patients exceeds one year, retraining of the individuals shall be
provided.
2. In addition to the
requirements of subsection (L) for therapeutic radiation machine authorized
users and subsection (M) for Qualified Medical Physicists, these individuals
shall also receive device-specific instruction initially from the manufacturer,
and annually from either the manufacturer or other qualified trainer. The
training shall be of a duration recommended by a recognized national
professional association with expertise in electronic brachytherapy (when
available). In the absence of any training protocol recommended by a national
professional association, the manufacturer's training protocol shall be
followed. The training shall include, but not be limited to:
a. Device-specific radiation safety
requirements;
b. Device
operation;
c. Clinical use for the
types of use approved by the FDA;
d. Emergency procedures, including an
emergency drill; and
e. The
registrant's quality assurance program.
3. A registrant shall retain a record of
individuals receiving manufacturer's instruction for three years. The record
shall include a list of the topics covered, the date of the instruction, the
name or names of the attendee or attendees, and the name or names of the
individual or individuals who provided the instruction.
P. Mobile Electronic Brachytherapy Service. A
registrant providing mobile electronic brachytherapy service shall, at a
minimum:
1. Check all survey instruments
before medical use at each address of use or on each day of use, whichever is
more restrictive;
2. Account for
the electronic brachytherapy x-ray tube in the electronic brachytherapy device
before departure from the client's address; and
3. Perform, at each location on each day of
use, all of the required quality assurance checks specified in this Section to
assure proper operation of the device.
Q. Medical events shall be reported to the
Department. For purposes of this Section "medical event" means a therapeutic
radiation dose from a machine:
1. Delivered to
the wrong patient;
2. Delivered
using the wrong mode of treatment;
3. Delivered to the wrong treatment site;
or
4. Delivered in one week to the
correct patient, using the correct mode, to the correct therapy site, but
greater than 130 percent of the prescribed weekly dose; or
R. A therapeutic radiation dose from a
machine with errors in the calibration, time of exposure, or treatment geometry
that result in a calculated total treatment dose differing from the final,
prescribed total treatment dose by more than 20 percent, except for treatments
given in 1 to 3 fractions, in which case a difference of more than 10 percent
constitutes a medical event.
S.
Reports of therapy medical events:
1. Within
24 hours after discovery of a medical event, a registrant shall notify the
Department by telephone by speaking to a Department staff member. The
registrant shall also notify the referring physician of the affected patient
and the patient or a responsible relative or guardian, unless the referring
physician personally informs the registrant either that he or she will inform
the patient, or that in his or her medical judgment, telling the patient or the
patient's responsible relative or guardian would be harmful to one or the
other, respectively. If the Department staff member, referring physician, or
the patient's responsible relative or guardian cannot be reached within 24
hours, the registrant shall notify them as soon as practicable. The registrant
shall not delay medical care for the patient because of notification
problems.
2. Within 15 days
following the verbal notification to the Department, the registrant shall
report, in writing, to the Department and individuals notified under subsection
(S)(1). The written report shall include the registrant's name, the referring
physician's name, a brief description of the event, the effect on the patient,
the action taken to prevent recurrence, whether the registrant informed the
patient or the patient's responsible relative or guardian, and if not, why not.
The report shall not include the patient's name or other information that could
lead to identification of the patient.
3. Each registrant shall maintain records of
all medical events for Department inspection. The records shall:
a. Contain the names of all individuals
involved in the event, including:
i. The
physician,
ii. The allied health
personnel,
iii. The
patient,
iv. The patient's
referring physician,
v. The
patient's identification number if one has been assigned,
vi. A brief description of the
event,
vii. The effect on the
patient, and
viii. The action taken
to prevent recurrence.
b.
Be maintained for three years beyond the termination date of the affected
registration.